Compare Gaming and Leisure Properties Inc. Common Stock (GLPI) vs uniQure N.V. Ordinary Shares (QURE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Gaming and Leisure Properties Inc. Common Stock vs uniQure N.V. Ordinary Shares — how do they compare? Gaming and Leisure Properties Inc. Common Stock trades at $38.13 (market cap $11.11B), while uniQure N.V. Ordinary Shares trades at $20.67 (market cap $1.45B). The key difference: Gaming and Leisure Properties Inc. Common Stock is far larger — about 7.7× uniQure N.V. Ordinary Shares's market cap, and Gaming and Leisure Properties Inc. Common Stock pays a 8.59% dividend while uniQure N.V. Ordinary Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold Gaming and Leisure Properties Inc. Common Stock for 0 Days and uniQure N.V. Ordinary Shares for 0 Days on average.
| GLPI | QURE | |
|---|---|---|
Market Cap | $11.11B | $1.45B |
Volume | 2,244,030 | 3,323,243 |
Sector | Real Estate | Health |
52-Week High | $49.82 | $70.59 |
52-Week Low | $37.59 | $9.03 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $19.17B | $707.46M |
Dividend Yield | 8.59% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Gaming and Leisure Properties Inc. Common Stock
Gaming and Leisure Properties Inc. is a real estate investment trust that acquires, finances, and owns casino and gaming properties, which it leases to gaming operators under triple-net lease arrangements. It was the first publicly traded REIT focused on the gaming real estate sector in North America.
Read more on GLPI →About uniQure N.V. Ordinary Shares
uniQure N.V. is a biotechnology company that develops gene therapies for rare and severe genetic diseases, marketing HEMGENIX for hemophilia B and advancing its AAV-based miQURE platform in programs such as AMT-130 for Huntington's disease.
Read more on QURE →
